To identify signaling pathways involved in citrate‐mediated tumor suppression in vivo, we found that administration of SCT activated MAPK and mTOR signaling pathways in HCT116 tumor cells in vivo (Figure 8H). This evidence concerns the gene MTOR and neoplasm.